Inventor · disambiguated record
Chetana Rao-Naik
Also filed as: RAO-NAIK CHETANA
13 granted patents·14 pending applications·229 citations·filing 2006–2023
92Inventor score
Files withBRISTOL MYERS SQUIBB CO13TERRETT JONATHAN A4MEDAREX INC3SQUIBB & SONS LLC2TERRETT JONATHAN ALEXANDER2
Top patents by PatentIndex Score
27 records- 0197US8268970B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2008·Granted Sep 18, 2012·65 cites·7 claims
- 0294US8399623B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Mar 19, 2013·25 cites·7 claims
- 0392US8097703B2CD19 antibodies and their usesRAO-NAIK CHETANA·Filed 2006·Granted Jan 17, 2012·71 cites·20 claims
- 0491US8383779B2Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 26, 2013·12 cites·7 claims
- 0590US8481683B2Human antibodies that bind CD22 and uses thereofKING DAVID JOHN·Filed 2007·Granted Jul 9, 2013·31 cites·20 claims
- 0688US8425904B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Apr 23, 2013·9 cites·17 claims
- 0786US9499632B2Human antibodies that bind CD22 and uses thereofSQUIBB & SONS LLC·Filed 2013·Granted Nov 22, 2016·8 cites·42 claims
- 0881US11623965B2Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 11, 2023·1 cites·11 claims
- 0980US9932411B2AntibodiesOXFORD BIOTHERAPEUTICS LTD·Filed 2014·Granted Apr 3, 2018·5 cites·24 claims
- 1072US8420084B2Fully human antibodies specific to CADM1TERRETT JONATHAN ALEXANDER·Filed 2010·Granted Apr 16, 2013·2 cites·22 claims
- 1171US2023295346A1Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1262US2009162372A1Fibronectin ed-b antibodies, conjugates thereof, and methods of useMEDAREX INC·Filed 2008·Application pending·0 cites
- 1360US2013190481A1Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1455US10676773B2Antibodies conjugatable by transglutaminase and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 9, 2020·0 cites·6 claims
- 1553US12290570B2Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and usesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 6, 2025·0 cites·23 claims
- 1652US2022251206A1Anti-ctla4 antibody prodruggable (probody) at a cdr positionBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1751US2011020329A1Conjugates of anti-rg-1 antibodiesBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1850US2012027782A1Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7)TERRETT JONATHAN ALEXANDER·Filed 2008·Application pending·0 cites
- 1950US2011085970A1Anti-b7h4 monoclonal antibody-drug conjugate and methods of useTERRETT JONATHAN A·Filed 2008·Application pending·0 cites
- 2050US2017058031A1Human antibodies that bind cd22 and uses thereofSQUIBB & SONS LLC·Filed 2016·Application pending·0 cites
- 2149US2013156788A1Fully human antibodies specific to cadm1MEDAREX INC·Filed 2012·Application pending·0 cites
- 2247US2010104509A1Human antibodies that bind cd19 and uses thereofMEDAREX INC·Filed 2007·Application pending·0 cites
- 2345US12478686B2Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and usesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 25, 2025·0 cites·5 claims
- 2444US2018362619A1Variant antibodies for site-specific conjugationBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2542US2017326249A1Antibody-drug conjugate of an anti-glypican-3 antibody and a tubulysin analog, preparation and usesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2640US2018282712A1Transglutaminase variants having increased specific activityBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2735US2018265851A1Transglutaminase variants for conjugating antibodiesBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →